Pharma manufacturing news in brief
December 7, 2010Manufacturing and Production A5 Laboratories, Adamis Pharmaceuticals, Beximco Pharmaceuticals, Caraco Pharmaceutical, Genethon BioProd, Jiangsu Yanshen Biological Technology, Viva Pharmaceuticals, contract manufacturing, gene therapy
Our round-up of manufacturing updates includes the world’s first dedicated gene therapy facility, hefty fines for a Chinese drugmaker plus …
EU regulators launch fresh raids on pharma
December 7, 2010Sales and Marketing AstraZeneca, European Commission, Losec, Nexium, Nycomed, Pantazol, Ratiopharm, antitrust investigation, esomeprazole, pantoprazole
Competition regulators from the EU have raided offices of AstraZeneca and Nycomed in connection with alleged attempts to block generic …
Laura Lane joins Black Swan
December 6, 2010Sales and Marketing Black Swan Analysis, Laura Lane, appointment, sales and marketing
Black Swan Analysis has appointed Dr Laura Lane to its Analysis and Forecasting team.Laura brings with her a strong scientific …
Roche’s MabThera successor shows phase II promise
December 6, 2010Research and Development, Sales and Marketing GA101, Genentech, GlycArt, MabThera, Roche, blood cancer, chronic lymphocytic leukaemia
The cancer drug Roche is developing as a second-generation successor to its blockbuster MabThera has shown promising results in a …
Surprise exit for Pfizer chief executive Jeffrey Kindler
December 6, 2010Manufacturing and Production, Research and Development, Sales and Marketing Ian Read, Jeffrey Kindler, Lipitor, Pfizer, Wyeth, executive succession
Pfizer’s chief executive Jeffrey Kindler has unexpectedly stepped down, saying his time at the helm of the world’s largest pharmaceutical …
NICE recommends MabThera for non-Hodgkin’s lymphoma
December 6, 2010Sales and Marketing MabThera, NICE, Rituxan, Roche, non-Hodgkin’s lymphoma, rituximab
NICE has given a preliminary green-light to Roche’s MabThera for use as a maintenance therapy for non-Hodgkin’s lymphoma. The Institute’s …
A mature approach to relationships with pharma’s customers
December 6, 2010Sales and Marketing MSI, Paul Stuart Kregor, franchise management, pharma marketing
Commercial managers who are responsible for a number of brands face a constant challenge in choosing where across the franchise …
Apitope appoints Hayley French
December 6, 2010Research and Development, Sales and Marketing Apitope, Hayley French, appointment, research and development, sales and marketing
Belgium-based biopharmaceutical company Apitope has appointed Hayley French to its management team as commercial director. She will be responsible for …
Caligor Rx strengthens its European Team
December 3, 2010Research and Development Caligor Rx, Jacquelyn May, Jess McKenna, appointment, research and development
Clinical trial procurement firm Caligor Rx has appointed Jess McKenna head of quality assurance and customer relationships and Jacquelyn May …
Digital Pharma: NHS extends online service comparisons
December 3, 2010Medical Communications Digital Pharma blog, NHS Choices, maternity services, patient information
The NHS has launched a new online comparison service to allow expectant parents in England to compare and rate maternity …
The specifics of early access programmes
December 3, 2010Sales and Marketing Expanded Access Programs, IDIS, early access programmes, named patient programmes
With increasing requests from healthcare professionals and patients globally for access to drugs that are still in clinical development or …
Merck acquires innovative insulin firm SmartCells
December 3, 2010Research and Development Merck, Merck & Co, SmartCells, diabetes, insulin
Merck has bolstered its early stage diabetes portfolio with the acquisition of SmartCells, a private pharma firm that’s developing a …
Creston makes £20m US coms acquisition
December 3, 2010Medical Communications Alembic Health Communications, Cooney Waters, Creston, Intensity Digital, Red Door Communications, medicial communications
Creston, the group which owns UK healthcare PR shop Red Door Communications, is to buy two US health and pharma …
UK pharma faces rising costs from value-based pricing
December 3, 2010Sales and Marketing Eli Lilly, VBP, lilly, value-based pricing
The government’s planned introduction of a value-based pricing system in the UK could increase costs and bureaucracy for the industry, …
Novartis to cut 1,400 US sales jobs
December 2, 2010Sales and Marketing Novartis, Novartis Pharma North America, Novartis Pharmaceuticals Corporation, job cuts, sales representatives
Novartis has outlined a major restructure of its US field force of sales reps that will see 1,400 positions cut …
Tolerx to collaborate on first-in-class cancer antibody
December 2, 2010Research and Development Cancer, T cell, Torelx, monoclonal antibody
US biopharma company Tolerx is to work with a non-profit cancer research fund to develop its first in class antibody …
CME Spotlight: medical communications evolves
December 2, 2010Medical Communications CME, CME Spotlight, Continuing medical education, Eugene Pozniak
I recently attended the first meeting of the MedComms Forum in Oxford. The venue of the Natural History Museum was …
Colour management for the pharmaceutical industry
December 1, 2010Manufacturing and Production colour management, packaging, pharma printing
The development and adoption of pharmaceutical specific quality standards by the printing industry has played a vital role in the …
EMA to widen public access to documents
December 1, 2010Research and Development, Sales and Marketing EMA, European Medicines Agency, European Ombudsman, patient information, transparency
The European Medicines Agency has agreed to give greater access to documents on medicines for human and veterinary use, after …
New chief executive for Merck & Co
December 1, 2010Manufacturing and Production, Research and Development, Sales and Marketing Kenneth Frazier, Merck, Merck & Co, Richard Clark, Schering-Plough
Kenneth Frazier is to be the next chief executive of Merck & Co from 1 January 2011 following his election …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
